分子亚型 |
|
| 0.473 | 0.789 |
三阴性 | 14 | 4 |
|
|
Lunminal型 | 9 | 3 |
|
|
HER-2过表达型 | 5 | 2 |
|
|
优替德隆治疗线数 |
|
| 2.633 | 0.105 |
≤三线治疗 | 11 | 5 |
|
|
≥四线治疗 | 17 | 3 |
|
|
Ki67%指数 |
|
| 7.674 | 0.006 |
≤30 (低表达) | 7 | 2 |
|
|
>30 (高表达) | 21 | 5 |
|
|
疗效评价 |
|
| 16.568 | <0.001 |
PR | 6 | 5 |
|
|
SD | 16 | 3 |
|
|
PD | 6 | 2 |
|
|